1.2400
29-4月-25 16:45:00
15 分の遅延
株式
+0.0300
+2.48%
本日の幅
1.2100 - 1.3000
ISIN
N/A
ソース
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 10 2022 09:00:00 提供 Nasdaq GlobeNewswire